Expanding service lines in community oncology practices enhances patient experience and strengthens community ties, offering ...

In this interview, Ann S. LaCasce, MD, highlights a late-breaking abstract on in vivo CAR T-cell therapy use in multiple myeloma, as presented at ASH 2025.

The faces of Maimonides Cancer Center’s pediatric patients were filled with joy and anticipation as they attended the annual ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Dr Benjamin George champions accessible cancer care in rural Nebraska, transforming patient support with innovative programs ...

Bhopal: A new digital health innovation promises to make cancer care more accessible and supportive for patients across India ...

For nearly a decade, Mayra Andujar-Delgado has navigated the complexities of living with myelofibrosis, a journey she says was fundamentally shaped by the steady, compassionate guidance of her ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

It was a great day in the dome. Another great performance on Sunday gets the rookie one step closer to ROTY. Some more tough ...

Mr. Williams is a seasoned corporate and nonprofit director with decades of experience in global finance, governance, and philanthropy, with a career deeply rooted in East Asia. He has served as an ...

Notably, the benefit was consistent across all prespecified subgroups, including premenopausal status and prior chemotherapy. Secondary end points also favored giredestrant, with a 31% reduction in ...

Policy, precision medicine, and new ways of delivering therapeutics were popular topics in 2025 among readers of ...